Ministerial Joint Decree No. 111094 including trifloxystrobin, carfentrazone-ethyl, mesotrione, fenamidone and isoxaflutole as active substances in Annex I to Presidential Order No. 115/97, in compliance with Commission Directive 2003/68/EC

22081 E<l>HMEPII THI KYBEPNHIEnI THI EMHNIKHI ~HMOKPATIAI TEYXOI ~EYTEPO Ap. <l>uAAou 1577 nEPIEXOMENA AnO<l>AIEII Kmaxwpriori TWV opamLKWV oumwv, trifloxystrobin, carfen­ trazone-ethyl, mesotrione, fenamidone KOL isoxaflutole ITTO nap6pTf]µO I TOU npm:opLKOU OLOT6yµmoc; apL8. 115/1997 «'EyKplOf], OL08Wr] ITTf]V ayop6 KOL 8A8VXOC:, cpurnnpommeunKwv npo·foVTwv ae auµµ6pcpwori npoc:,Triv ooriy(a 91/414 Tou foµ[3ou"ALou, 6nwc:, exet au­ µn"Aripw8e(» (A 104), ae auµµ6pcpwori npoc:, TrJV Ooriyia 2003/68/EK n1c; EmTpon17c; n1c; 11 ric; lou"ALou 2003 ...... . AnO<l>AIEII 27 01crw~p(ou 2003 Kf, amSTO 6.p0po 6TOU v.1440/1984(A' 70) KOL TO 6.p0po 65 TOU N.1892/90 (A' 101). 2. TUUfJ8fJU 14, ILEfJLILI. KUL LUU N.721/77 (A298), UILUJ~ npoon:817Ke µno 6.p8po 8 nap. 3TOu N. 2732/99 (A 154). 3. To 6.p8po 29ATOU N.1558 /1985 «Kul3epv17017 KOL Ku­ l3epv17nK6. 'Opyava» (A 137) 6nwc; TO 6.p8po auT6 npo­ mt017Ke µeTO 6.p0po 27TUU N.2081/1992 (A 154) KOL OVTL­ KOTOITT0.8l7K8 µ£ TO 6.p0po 1 nap. 2a TOU N.2469/97/A 38) KOL TOU y£yOVOTOC: OTL Ono TLC: OLOT0.S£LC: Tl7C: napouaac; an6cpao17c; osv npoKa"A£iTOL oam1v17 a£ !36.poc; TOU Kpan­ Kou npounoi\oytoµou. 4. T17v 0017y(a 2003/68/EK TllC: EmTpom']c; TllC: 1117c; lou­ "Aiou 2003 (E.E. Ap. L 177/12 TllC: 16.7.2003) YLO Tl7V KOTO­ XWP17017 opamLKwv oumwv trifloxystrobin, carfentrazone­ ethyl, mesotrione, fenamidone KOL isoxaflutole mo nap6.p­ T17µa I TllC: 0017y(ac; 91/414/EOK TOU LUµl3ou"A(ou oX£TLK6. µ£ Tl7V OL0.8£017 <pUTOnpOITTOT£UTLKWV npo"LOVTWV ITTl7V ayop6.. 5. T17 399580/30.10.2001 (<DEK 1479/B/ 31.10.2001) KOL­ Vil an6cpao17 Tou npw8unoupyou KOL Tou Ynoupyou 1£­ wpyiac; yLa «av68£017 apµooLOT'lTWV Ynoupyou rswpyiac; moue; Ycpunoupyouc; rswpy(ac; Eu6.yys"Ao Apyup17 KOL Ci>WTll Xml;17µLXd.i\17», anocpao(l;ouµe: Ap8po 1 (6.p8po 1 TllC: Oo17y(ac; 2003/68/EK) 0 n(VOKOC: TOU napapT11µmoc; I TOU n.£1. 115/97 Tpono­ noL£1TOL WITT£ VO KOTOXWpl780UV Ol OpOITTLK£C: OUOL£c;: tri­ floxystrobin, carfentrazone-ethyl, mesotrione, fenamidone KOL isoxaflutole ouµcpwva µ£ TO nap6.pT17µa TllC: napou ApL8. 111094 (1) oac;. Kmaxwp17017 Twv opaITTLKwv oumwv, trifloxystrobin, carfen­ trazone-ethyl, mesotrione, fenamidone KOL isoxaflutole OTO nap6pT17µa I TOU npoei5pLKOU i5LOT6yµOTOC:, apL9. 115/1997 «'EyKpLOl7, 016.8e017 ITTl7V ayop6. KOL e"Aeyxoc; cpurnnpoOTOT£UTLKWV npo"i6VTwv oe ouµµ6pcpwo17 npoc;T17v 0017y(a 91/414 TOU Luµl3ouh(ou, 6nwc; exeL ou­ µnA17pw9d» (A' 104), ae ouµµ6pcpw017 npoc:,T17v Oi517y[a 2003/68/EKT17c; EmTpOTI'lC:TllC: 1117c; louh(ou 2003. 01vnOYP10I OIKONOMIAI KAI OIKONOMIKQN 1E!2PrlAI: 'ExoVTac; un6ljJ17: 1. To 6.p8po 1 nap.1, 2 KOL 3 TOU N. 1338/1983 «Ecpap­ µoy11 Tou KoLvonKou LlLKa(ou» (A 34) 6nwc; TpononoL11817 Ap0po2 (6.p8po 3T17c; Oo17y(ac; 2003/68/EK) a. H ElLeu8uv017 npomao(ac; (J)unK11C: napaywy11c; (Tµ11 µa rewpy1Kci:>v <Papµ6.Kwv) mu Ynoupyeiou rewpy(ac; enaveseT6.l;8L nc; ucpLOT6.µevec; eyKpl08LC: YLO K0.08 cpUTO­ npoOTOTeLITLKO npo"i6v nou m:p1exe1 TLC: opam1Kec; ouo(ec; trifloxystrobin, carfentrazone-ethyl, mesotrione, fenami­ done KOL isoxaflutole £TOL ware va 01aocpaM~ern1 6n T17 pouVTOL OL OpOL OL 8KTl0£µ8VOI OTO napapT17µa I TOU n.Ll. 115/97. E6.v eivOL avayKa(o nc; TpononOLei 'l nc; avaKahei µexpL T17v 3117 MapTiou 2004 TO apy6Tepo. 13. 1La K6.0e eyKeKpLµevo cpuTOnpommeuTLK6 npo"i6v nou nepLexe1 trifloxystrobin, carfentrazone-ethyl, mesotri­ one, fenamidone KOL isoxaflutole etTe we; µovaoLK'l eiTe we; Ap0po 3 llAP APTH:vtA ( TTapupniµa ,l]c; O8l]yiac; 2003/68/EK) Kmmtp@ 1tapm:l0i:1:at 1:0 1tapap1:T]µa nic; napoocrac; mr6cpu<JT]c;, 1rou an:01:i:Mi avunocmacrrn µi:poc; ami]c;, Km txi:1 coc; i:~i]c;: Ap. 59 KmviJ ovoµauia Km Uf)l(lµoi muroroincrnc Trifloxystrobin CAS No 141517-21-7 CIPAC No617 Ovo µa<Jia !UP AC I Methyl (E)-methoxymino-{(E)-a• [ 1-a-( a,a,a-tri fluoro-m-tolyl) ethylideneaminooxyl]-otolyl} acetate Ka0ap6TI]TU 960 glkg 'Evap~l] t")'.DO\ 1-10-2003 Afi~ll TI]<; KUTUJltler!<".lS 30-9-2013 !StaitEpot 6pm E1mpi:it£Tm va i'.PJJ<nµo:rowirat µ6vo COS µUKJJTOKTOVO. rta HJV E<papµoyfi TCOV tVlCllCOV apxcov wu napaprfiµaws VI itpEitEt va ),aµf3civovrn1 UltO\j/lJ Ta cruµitspcicrµam TIJS i:K0EcrJJ, avacrK61tricrJJs y1a tl]V trifloxystrobin, Kat tliico; rcov npocrapniµcircov I Km II, 6ncos optcrnKOltotfi0JJK£ 0-TO ltAlttcr\O HJ~ µ6v1µ JJS Emtponfi; yw Tl]V rpocpttj a1-ucr(8a Km TlJV uyEia roiv i;wcov crns 15 AitptAlOU 2003. ~ L Tl] cruvo1-1Kfi aurfi EKriµl]CTl] lJ Apµ68m APXfi ocpi;iA£1 va aitoli(list 18taiTEplJ npocroxfi crrriv iiuvaµEt µ61-uvcrJJ rou urr6yEtoU u6pocp6pou op«;ovm 6mv lJ 8pacrrtKfi oucr[a Eq>ap,16i;Erm crE m:pwxi:; µ£ wrra0i:; siimpo; fi/Kat EU:n:a0Eis Kt.tµaroAOylKES cruv0ijKE<;. C:la :n:pi::n:Et va £cpapµ6i;ovmt, 61to-rE SVOElKVUTUl. µtrpa aµ /3AUV!Jl]S rou K\VOUVOU fi/Km ltpoypciµµara :mpaKoAOu8JJCTJJS '" '" -< ::J W 0- -C g J5 ~- 0 '5 ~ 6' (')0-0 .n ::J<COM 0 0 • 5 ,-< (') '" ::l t> -- C'l 8 ;:j 0 o ~Ji 8-::; (') ::J01 0 ~--c ;;; 0 -< .n v:> 0 O, ~ -0 --~ -0 -0 -6 ~ >< 0 -I , O· o co ('),.n -c O -0 -0 CO .n ::l .::::l, C ,-i C'l ..J -O-cr\l.::::l.n • ::l O O O-C v:,0v:, 00 01 0• C O 7 .i::,. --o a ::l <' <"" .::::i .3 o ~-o ~~ t>.n Sl M 0 a-<-o­<=,.,-<""o,;,; o>'.::::i;,;c- C'l, .n' g- < 8- g>~ .n o o < < -·o °8 ;:i-!!160}5 C ;,; oo.::::icoo ('), 8 >' -0 ::J ~ cry' >' a o--c -o -----.n 0 ,., -< o- o .i::,. CO .::::l;,; Q ~ ::l ::l::l08,, o o o.::::i.s,o me C -0 Q ,., 9, 0 ::l ::l 0• C, 0 0 ;,:; C'l ;>---o-i= c.n-c-o .::::i '" -e -< e ('). 0), 0~8::lc~>< O>-< ,-iuO 0 O g ;i; ::i ;:i ;:j <1= -0 .::::l,.::::l 0 f) (') ,fl< a a~-§~~§ C >'>< • .::::l Q 0 (') ~- -g :z -0 .::::l ;:j 5i '" '" ~ Q, '" .::::l, O.::::ljj;:.. ,.,.::::i g C<w010< .n C'l,~~ C 0.n O-< ;,;.n.fY1,, c;,;S:::80--0 3"9-§~-g ~c C· q ,-i ~ C O, ::l • .::::l 5· '" .n -< 0 <cO,.,.::::l-O C O O 0 O~:::ic.::::l-o 6 0 [> o- 0 3, co~- -g,Si-c (') 0 :::::: -0 .::::l- ~ eo010;,;o c-o-----co.n ,.,-<<D.i::,.CD= 0 0- :--,I. 0 ::l'"m::l-o,., o C'l O O -- 0 o"D •-o.rsc a o < o- £l :::i '" '" ~--< 0 • 0-0<-0-[> '"0 0 0 C'l • 8 ::l 0- -6 O· ~ ,,o<o<~ ,;;::lo.n,,5:!2 0, Q-< ~ 0 ~ ::l ~- 6 (') ::l ~ 0 .::::l- -- 01 -0 ---..J 0 0 0 o- 0 • 5: a a-§ 5: s: < ' - 0 < (') N N 0 co N m e :I: s m "'C M l :I: M ;:,:: < CJ m "'C z :I: M m :0 M '-=l m < >< 0 M t> m < l m "'C 0 Ap. 60 Kotvi] ovoµacria rn1ap10µoi TaUTmtoin<rnc Carfentrazone ethyl CAS No 128639-02.1 CIPACNo 587 Ovoµacria IUPAC Ethyl (RS )-2-chloro-3-[2 chloro-5-( 4-difluoromethyl 4,5-dihydro-3-methyl-5oxo 1H 1,2,4-triazol-1-yl)-4 fluorophenyl] propionate KaBap6TIJTa 900 g/kg 1ovap1;11 lcr;(UO<; Af]l;q TI']<; KmaxcoprimE 1-10-2003 30-9-2013 l&tain:pot 6pot E1ttTpE1tETm va XPT1crtµono1£im1 µ6vo coi; (ti;avwt:t6vo. fta TT]V Ecpapµoyi] TCOV EVtaicov apxwv TOU napaprfJµarni; VI npbm va .. aµ~civovmL u1t61j/T] m cruµrrspcicrµarn TTJS EK0scrrii; avacrKOITTJO"T]<; yta TT]V carfentrazone ethyl. KU! toicoi:; TCOV 11pocraprriµciTOJV J KU! II, 61tcoi; op1crnK01101fJ0T]KE crrn n:t-aimo rrii; µ6vtµ rii; Em,porrf]i; yta TTJV rpocptKf] CtA.UO"lOCt Km TT]V uy£ia TCOV (rornv crni:; J S A11ptAiou 2003. H Apµ68ta ApxiJ OtpEU£t va arrooioi-:1 18iaiti-:p11 npocroxiJ crrriv 11pocrracria rov un6yi-:wu u5p0<p6pou opfl;ovm 6rnv 17 opacrnKfJ oucria sq,apµ61;i-:mt crE nEptoXES µE run:a0E<; t&icpoi; fJ/Km wna0Ei~ KAtµarnAoytKE<; =v0TJKE<;. 0a 11pE1tEt va Ecpapµ6t;ovrm, 61toTE EVbEtKVUmt, µfapa ciµ~A1JV0"17<; rou KlVbUVOU. m e ::I: :s:: m "'C i-:1 l ::I: M ~ CIJ m "'C :z ::I: M m :::i M =i m ~ 0 M t> m < l m "'C 0 N N 0 o:i vJ Ap. KotVll ovoµauia Ovoµacria IUPAC Ka8ap<'iTI1T«1 ica1up18µoi ,au'to1to(ncmc 61 Mesotrione 2-( 4-mesyl-2-nitrobenzoyl) 920 g'kg CAS N.o 104206-8 cyclohexane -1,3-dione H 1tp6crµ~TJ 1tou CIPACNo625 O<pElAEt"Ul O"TTJV xapao,ceuft 1-cyano-6 (methylsulfonyl) 7-nitro 9Hxanthen 9-one 8eropeitat 6-rt 7tp0Ka.A.El to~lKOAOylK(l 1tpop1.ftµatll Kil\ 1tptm,1vll 1tapaµeive1 Katm ll7t6 0,0002% (w/w)cr-ro tEl\ltKo 1tpoi'.6v 'EvapslJ J.CJXUO!i A11s1J Tll'i lotai'ti:pot opot lCU't«:X.OlPlJOTl~ 1-10-2003 30-9-2013 EmrptJtE'tat va XPJ1cnµo1t0Ulitm µovo ro~ ~~avwicr6vo. rta TTJV E<papµoyft 'tOJV evtaic:.ov UPX.WV 't01l n:apaprftµaroc; VI n:pE7tEt VCl mµpavOV'tat u1t61VTJ 'ta cruµn:epacrµlltll TTJc; tic8scrT)c; llVllcrK67tl10"T)c; yta TTJV mesotrione, Kat ioiOJc; wv npocrllpl:fJµa-rmv I Km II, 67tmc; Opl<H\K07t0\'1)8T}KE cr-ro n:mimo TT]c; µ6vtµ11c; E7tltpoIDJc; yta 1:lJV rpocptKiJ a,.,ucriooc Kill TTJV uyeia 'tOJV ~ffl(l)V crtti; 15 An:pu.iou 2003. I\) I\) 0 (X) ~ m e :I s m ""C M I :I M ~ m m ""C z :I M m ::J M =i ~ 0 M t> m ~ m ""C 0 ci. -«: E<PHMEPII THI KYBEPNHIEilI (TEYXOI ~EYTEPO) C') 0 0 N 0 -' 22085 Ap. Ko1viJ ovoµaoia Ovoµacria IUPAC Ka0apoTT]ta 1 'E vap~TJ tcrx(,<X; Aii~IJ TT]; Km upt0µoi ICCTtaXOlPTJCTTJ<; T(lUTQl[O[nan~ 63 I .Isoxaflutole 5-cyclopropyl-4-(2-methylsulfonyl- 950 glkg 1-10-2003 ~0-9-2013 CAS No 141112-29-0 4-tri fl uoromethylbenzoyl) CIPAC No 575 isoxazole l 1 flepmrepro :\.en:roµepni::; crxrnKa µe rriv taUTO'tl]TU Km ns irpoowypa,:pec; TI]; opacrTIKTJS oucrias oivovmt OtrJV €K0ecrrt avUOKOltl]O"l]S l&tait&po1 6pm Emrpi\1m:m vu )(pl)crtµon:ou::irm µ6vo cos st~(lVtOKtOVO. rux r11v eq>apµoyiJ mv evtaicov UPXWV rou napapTT]µmos VI 11pi :et va 1uµl36.vovm1 un:61jll] m cruµm;pa.o-µuro. tl]<; e1e6ecr11i; avacrK671:l]crlJs yia TI]V isoxaflutole, Km 18icoi; rwv 1tpocrup1:11µarcov I Kill II, 6n:coi; optcrrtKOlt011'}011KS cr10 1iAalO"lO tl]<; µ6v1µ11i; i:1mpom')i; yia tl]V rpoq>lKTJ alucrifo Kat r11v uyeiu rwv swcov crni; 15 Anpv,iou 2003. Ir11 crt>VOA.llCTJ UUTT] rt Apµ66m ApxiJ~ o<f)etA.et va arrooioet t8wirsp!] npocroxiJ: crtl]V npocrracria rou un:6yi:1ou u8po1p6pou opil;ovm 6ruv ri opucrnKTJ OUcr{u e<f)UpµosEtCll cre m,p!OXBS µe ruiraets €6(l(po; i]/1em t111ta9eii; KA1µuro1.oy11ee; cruvth'!Ke<;. 0a npfat:1 VU E<papµ6sovrat, 01iOn; EV◊e!KVUtUl, µstpa aµl31.UVCfT]<, tOU KlVOIJVOU. N N 0 co Ol m e :I: s m "'C M l :I: M ;:,:: < CJ m "'C z :I: M m :0 M '-=l m < >< 0 M t> m < l m "'C 0 E<PHMEPII THI KYBEPNHIEilI (TEYXOI ~EYTEPO) Ap0po4 (6p0po 4 n1c; Oi517y[ac; 2003/68/EK) OL i5Lm6snc; T'7c; napouoac; ano<pao17c; LOXUOUV OTTO T'7c; i517µomeuoewc; Tile; m17v Ecp17µep(i5a Tile; Kul3epv~oewc;. H anocpam7 auT~ va o,iµomeu0ef on1v Ecp17µepfi5a Tile; Ku l3epv~ oewc:;. A0~va, 22 L8meµl3p(ou 2003 OIYnOYP,01 OIKONOMIAL KAI OIKONOMIKON N. XPIHOllOYAAKHI Y<DYnOYPrO,: ,EOPr-lAL EYArrEAOI APrYPHI 22087